Tommy Kenny
General Counsel at INTELGENX TECHNOLOGIES CORP.
Net worth: 29 436 $ as of 2024-03-30
Profile
Tommy Kenny has held multiple positions in the legal field.
He is currently the Vice President-Legal Affairs & General Counsel at Intelgenx Corp.
and has been in this role since 2021.
Prior to this, he served as the Senior Vice President & General Counsel at IntelGenx Technologies Corp.
starting in 2016.
Additionally, Mr. Kenny currently works as an Associate at Brouillette & Partners.
In terms of education, Mr. Kenny holds a graduate degree from the University of Sherbrooke and a undergraduate degree from Bishop's University.
He also obtained a graduate degree from the University of Montreal Law School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-28 | 167,250 ( 0.10% ) | 29 436 $ | 2024-03-30 |
Tommy Kenny active positions
Companies | Position | Start |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | General Counsel | 2015-12-31 |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | General Counsel | 2020-12-31 |
Brouillette & Partners | Corporate Officer/Principal | - |
Training of Tommy Kenny
University of Sherbrooke | Graduate Degree |
Bishop's University | Undergraduate Degree |
University of Montreal Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Private companies | 2 |
---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Brouillette & Partners |
- Stock Market
- Insiders
- Tommy Kenny